The implementation of the "Healthy China 2030" Planning Outline has ushered in rapid development of China's big health industry.
The industry scale expected to reach RMB 8.78 trillion in 2019 and RMB 14.09 trillion in 2023, calculated as per the about 12.55% compound annual growth rate in the next five years.
With the implement of generic drug Consistency Evaluation and Marketing Authorization Holders system, Chinese pharmaceutical industry is focusing more on quality and innovation.
Second CIIE concludes with 71.13-bln-USD tentative deals.
The second China International Import Expo (CIIE) concluded on Nov 10, with 71.13 billion U.S. dollars’ worth of tentative deals reached for one-year purchases of goods and services.
